SPNS2 and autoimmune disease: Mainly the fact that blood S1P levels are reduced by 40% in Spns2-deficient mice [16] and that these mice are lymphopenic suggests that T lymphocyte-driven inflammatory and autoimmune diseases can in principle be reduced by Spns2 downregulation or inhibition.